In a UK trial, the same vaccine was found to be 89.3% effective, Serum
CEO Adar Poonawalla said.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/indias-serum-institute-seeks-approval-to-conduct-local-trial-for-novavax-covid-19-vaccine/articleshow/80557135.cms
No comments:
Post a Comment